{"ticker": {"uuid": "f8dc58b3-5d12-40b0-9a39-fe0719478f1f", "symbol": "ABT", "name": "Abbott Laboratories", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Abbott stock powers through 100-DMA, but long-term downtrend still looms (ABT:NYSE)", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQSGxrSDZvMDVHSkxRYlZBOTFsVk9lY1M5M0xFM1dJVTgtWXBJU2Q1azAyeW5TcUVzelg3LUNwOWR1Wkl5Z0hfVUZFWnY3bW5wNlJiSnJHUV9VVTNSR09OYU5wZTRnVFUtVWpfTnhqdFVadThEdEFuV1JDcmxXZXc2ckpHMU1GVW94Y1RvYzM5NlgtODc2UGNJeVVNWkNRWHNFYV82QmdXZ09vbV96WGc?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-16T16:51:30+00:00", "published_display": "16 Jul 2026 16:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott (ABT) Shares Rise 10.7%", "summary": "", "url": "https://news.google.com/rss/articles/CBMic0FVX3lxTFA4ZlBHYWgwSllfcDZQdjhCMnN0bW9YMmtIeWQ4bHJ3VVEzSUgxWlh4TmFNVnlscktjMWJKNy04dGU4YkttRkFjRjQyZjVKWWdNbFE0d3kzWGZVS3FKY1hvcElNNHMzeldxX0lBS1Z5U2hwQlE?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-16T16:45:34+00:00", "published_display": "16 Jul 2026 16:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories Stock (ABT) Rallies on a Q2 Earnings Beat and a 2026 EPS Guidance Increase", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPa3c2bjJkZEtrNF82Tl9HLTRpM0pWNExtNjBKOUgxRTY1dm5KbTR0a3J4UFdOeFBBWDlwVG9jUDdZdGNSb19FSzMxbG4zSjN0Q29Ta3JWanRNR25rSXNWZnlWdGNpVm4zMGxsbE5JSUJ3WXJGWS1XcmFDQkdPanFPUVMwUlo1MXZLTWJ4SFA5TFN3bi12MC1OOS11cmtLUTNWMGNyajFobTdOWWF5X1NZNDFSNmRaWjV1SlZ5Q3RYaw?oc=5", "source_name": "TipRanks", "published_at": "2026-07-16T16:36:28+00:00", "published_display": "16 Jul 2026 16:36", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories shares jump as earnings beat estimates and company raises 2026 outlook", "summary": "", "url": "https://finance.yahoo.com/m/84518966-d2b7-301d-86f8-a7605f549215/abbott-laboratories-shares.html", "source_name": "Proactive", "published_at": "2026-07-16T16:23:00+00:00", "published_display": "16 Jul 2026 16:23", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stock Market Today: Nasdaq Slides While TSMC Hits Sell Rule; Abbott Soars (Live Coverage)", "summary": "", "url": "https://finance.yahoo.com/m/c5561775-6f2a-30c3-8319-d6feaa5d3578/stock-market-today%3A-nasdaq.html", "source_name": "Investor's Business Daily", "published_at": "2026-07-16T16:08:01+00:00", "published_display": "16 Jul 2026 16:08", "sentiment": "negative", "sentiment_pct": 42, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stocks making the biggest moves midday: Manpower, Abbott, UnitedHealth, TSMC & more", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxPaUJKazRxOGhsbTJBaDB2ZkhVa2k1cDFIdTZtc1hnMWNNbjJRRzFRSmxyNkM1SFRMdVVDSlMyT1hrQW9BN09Qd3BPTXl3LXlmOEZyNmsxaFFETVB0eTVYRGsyNVd2bzlVeUpRcURIQjBBSC04aU1XQlB4TkNDMS1XR0hjeXRfbGpZNzczTG92NUZrYjZ5VktfOUNoeXY?oc=5", "source_name": "CNBC", "published_at": "2026-07-16T16:03:48+00:00", "published_display": "16 Jul 2026 16:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Q2 Earnings & Revenues Top Estimates, Stock Up in Pre-market", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/abbott-q2-earnings-revenues-top-155000355.html", "source_name": "Zacks", "published_at": "2026-07-16T15:50:00+00:00", "published_display": "16 Jul 2026 15:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Abbott Stock Is Having Its Best Day in 24 Years", "summary": "", "url": "https://finance.yahoo.com/m/70706931-299d-39fa-826f-4e8791c41c0c/why-abbott-stock-is-having.html", "source_name": "Barrons.com", "published_at": "2026-07-16T15:48:00+00:00", "published_display": "16 Jul 2026 15:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Stock Is Leading the S&P 500 After Earnings for Its Best Day in 24 Years", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE9nWkpfejFEQ0ozN0taTzJ5ZTRnWUVtUjUzZDJ5MEZKZnphQ1ZJaGlxMDhGMENWb3lWM3dKcWIzTWhKVE1JWXM4Z0Z3eGVrUVo5NjBNX0Y5OVc0UkVVZU1fLThrazZiQnRRS0lqbG1kWkQ4LXRxcUw0Xw?oc=5", "source_name": "Barron's", "published_at": "2026-07-16T15:48:00+00:00", "published_display": "16 Jul 2026 15:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories: Double Beat And Raise Surprises The Street (Rating Upgrade) (ABT)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxQbVJxakpNQ3hMemFxYjRCdjFTUGlpMGRpN0F5U1o4Q0M3TlJISDhXMzFHTDBPclk2aF9uWUVmNGpkOXRZTWxOZWpqSEV1cG1xbHktSW4tc2VpMXZVWi1vS1UyTTAwTGN0UnVBOGt5X2M2c3VUSXE4QXhzdi1VRU1WY0l4ay1zTktuTXpSalM3N3BCTGoyTkFCbmxqeFIyb2FnaHRQRDBuYWdaUVRzWm1CZVB4YWQ3YzA4SHJNWUVkVmh4aHBGQXlTMnhCN3lPZW5VRkM4?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-16T15:46:22+00:00", "published_display": "16 Jul 2026 15:46", "sentiment": "positive", "sentiment_pct": 95, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories Q2 Earnings Call Highlights", "summary": "", "url": "https://finance.yahoo.com/m/f558be41-72a2-3ca2-bc1a-1d4232b60495/abbott-laboratories-q2.html", "source_name": "MarketBeat", "published_at": "2026-07-16T15:04:48+00:00", "published_display": "16 Jul 2026 15:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott (ABT) Sees Significant Stock Surge of 12.5%", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOGI5YlV1YU5sTE05Z0lPZktQX244TTRldWZ6ZGU4UTllRGtkMTJ5dDA4d01QLVZVQ2xES2JINkh0N0hmVlJaY1lMU1FQRGRoaV82bW9sUUNWRzcyNzVBc2JSX3k0cVpiR1R3eThtZnc2WjFqUGItOHJJM1U5SXJYVloxeDhVM1lJLWgtWVBn?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-16T14:49:03+00:00", "published_display": "16 Jul 2026 14:49", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Stock Soars 13% On Earnings Beat, Guidance Raise - Abbott Laboratories (NYSE:ABT)", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxQTTQzNUdJdGFUc3h0Rmlnb2FlcmJ0ZEU5dHF2VFBEelBObW43QTFleVBhV0F4YUp2QlRSdkpVUEpHU0paNGxZcFk2Um03NWlRY1dSWmh3VVFMSkYwTjdMWHh6N2ZNMC0zMG9uMkFqb205U19lTlhwWmJiZ1FrSG9BSi13SUNkMGZaeWhJXzI5cmVObjJVNnNtbFdNa0w2dmUxUkR6SmlacC1mXzRObmg0YzE1SV8?oc=5", "source_name": "Benzinga", "published_at": "2026-07-16T14:45:35+00:00", "published_display": "16 Jul 2026 14:45", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories Raises Full-Year Earnings Guidance as Second-Quarter Results Top Views", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/abbott-laboratories-raises-full-earnings-143219434.html", "source_name": "MT Newswires", "published_at": "2026-07-16T14:32:19+00:00", "published_display": "16 Jul 2026 14:32", "sentiment": "positive", "sentiment_pct": 58, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott, Up 14%, Strikes Three-Month High After Boosting 2026 Profit Outlook", "summary": "", "url": "https://finance.yahoo.com/m/91665efd-7328-3275-ad41-358ac40e9854/abbott%2C-up-14%25%2C-strikes.html", "source_name": "Investor's Business Daily", "published_at": "2026-07-16T14:22:04+00:00", "published_display": "16 Jul 2026 14:22", "sentiment": "positive", "sentiment_pct": 58, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Abbott Stock Is Reimagining Its Future", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNSk5SNVotQmFsQTU5bnBOcG1wSmtvcDI4Q0lEZUJ1eU9YSUtlVTJ5TVBGT29Obl81a19DLVIxdXVsVHBsR3lzdjFkdGt6Yjc5QzNLN3Ewa3VDcHJVbXVIZ2h2VFMyeGVuNWVHZE1FQngteEMzNU0ycHB1UWhJZ2RQOXdYSUQ5elU3S1FvUXFwV1BNdUo1WUV0TGRoRk5YTXNqRXNJVg?oc=5", "source_name": "Trefis", "published_at": "2026-07-16T14:07:55+00:00", "published_display": "16 Jul 2026 14:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott raises 2026 earnings outlook after second-quarter results beat expectations (ABT)", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxPTWVlcHQyeTR0aWE2TnFnX05oWVA3ZWRDWk80UHJGTm5sNDJkSGF3dTdDRlVBMnZKaTIwYXpFWk5SbVNzWGVublFyZlBlSjZIQW5OcnBPNFZPbGtGVnRLbFNIaFRhaTduZ0Uxd1RaN2V5RkdhX0FlcWFsSFVFR1ZDcGZhQ1hNcE1QV1RYTmd2UTBzRF9LLWJRVWpsR0I?oc=5", "source_name": "Market source", "published_at": "2026-07-16T12:43:10+00:00", "published_display": "16 Jul 2026 12:43", "sentiment": "positive", "sentiment_pct": 95, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott rises as guidance hike tops expectations (ABT:NYSE)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxNY1ZVekxEbHNpT3hrcUlBaUlyV09wVmwySGl4NTB6Rnk0ZllYN1prbWhjV1gzaHhQNWdXX1dlYlZva2xWcFpGaTRHQjNCM3BGU1NBWWduUlk2Q1FTVzZIXzgtbERucUJtMnVMeUI0WjZtQmZhNXZfVkNkZG5aYWo3b1NuTUFJTEk1OEE?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-16T12:39:07+00:00", "published_display": "16 Jul 2026 12:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories NYSE:ABT Rises on In-Line Q2 and Raised Guidance", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQbEc5NmplWklTZ3ZuMlMyUTI2MzJxdDZiREF4dzRDSDM4TlBLcnRjWm9OSmNwMDlJS0U1UWp2SWhIb3FIYW9qNVRPTFNjR0RXVk10b1kxNkx5MnJTN1RRWmZSRU9weU91OVFzZ0pXTTVEWmVJM2dhVjJVaWNmelJrUDBobF80R0QwZzdMOU1JaERWSnAyeDQtY19HZDFEcEVUMTZnNFMxSkJzM0lsNG9xQW0zLXZ5aWNkaVE?oc=5", "source_name": "ChartMill", "published_at": "2026-07-16T12:20:15+00:00", "published_display": "16 Jul 2026 12:20", "sentiment": "positive", "sentiment_pct": 68, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Abbott Laboratories (ABT) Below Fair Value After Its 31% Fall?", "summary": "Abbott Laboratories (ABT) has experienced a 31% stock price fall over the past year, leading to investor sentiment turning negative. However, both discounted cash flow (DCF) analysis and traditional market multiples suggest the shares are currently trading at a discount. Despite ", "url": "https://finance.yahoo.com/markets/stocks/articles/abbott-laboratories-abt-below-fair-131308260.html", "source_name": "Market source", "published_at": "2026-07-16T13:12:59", "published_display": "16 Jul 2026 13:12", "sentiment": "positive", "sentiment_pct": 70, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ABBOTT LABORATORIES ($ABT) Releases Q2 2026 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxOU1gtODRaaExTNkxwWl9nQzh1OTJ5NlhtWGtUd3lwMnVldWU2RzJoNG5LX3ZNOGNIcW1Ra0cwZHdDemFsTWhQeldkZFZ0em1EUDY2ZV9SejdnbnRfR2RFWFdSNkdGcGVwOWV5SHVCdTRHb005enVSUHY5ekpSTFJBUmRzeC1Bck96Qm9KY2Z2ZnhqV0Znc0E?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-16T11:55:00+00:00", "published_display": "16 Jul 2026 11:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Boosts 2026 Profit Guidance as Sales Across Business Rise", "summary": "Abbott Laboratories has increased its 2026 profit guidance following a better-than-expected second quarter. The company now anticipates adjusted earnings per share to be between $5.45 and $5.60, representing a 5-cent improvement at the midpoint. This positive outlook is attribute", "url": "https://www.bloomberg.com/news/articles/2026-07-16/abbott-boosts-2026-profit-guidance-as-sales-across-business-rise", "source_name": "Bloomberg.com", "published_at": "2026-07-16T11:42:09", "published_display": "16 Jul 2026 11:42", "sentiment": "positive", "sentiment_pct": 80, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance", "summary": "Abbott announced its second-quarter 2026 financial results, reporting a 13.0% increase in sales and a 4.8% comparable sales growth. The company also raised its full-year 2026 adjusted diluted EPS guidance to $5.45 to $5.60, up from the previous range of $5.38 to $5.58. Key busine", "url": "https://www.prnewswire.com/news-releases/abbott-reports-second-quarter-2026-results-and-raises-full-year-eps-guidance-302827508.html", "source_name": "PR Newswire", "published_at": "2026-07-16T11:29:57", "published_display": "16 Jul 2026 11:29", "sentiment": "positive", "sentiment_pct": 73, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Employees sue medical giant over excessive healthcare costs", "summary": "A group of Abbott Laboratories employees has filed a class-action lawsuit alleging they were overcharged for health insurance plans that offered no additional benefits. The suit claims Abbott offered two plans with the same medical coverage but different costs, violating the Empl", "url": "https://www.courthousenews.com/employees-sue-medical-giant-over-excessive-healthcare-costs/", "source_name": "Courthouse News", "published_at": "2026-07-15T17:35:03", "published_display": "15 Jul 2026 17:35", "sentiment": "negative", "sentiment_pct": 30, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reasons to Retain Abbott Stock in Your Portfolio for Now", "summary": "Abbott Laboratories (ABT) is recommended as a stock to retain due to strong performance in its Nutrition business and growth in emerging markets within its Established Pharmaceuticals Division (EPD). However, potential headwinds include currency fluctuations, a dull macroeconomic", "url": "https://www.tradingview.com/news/zacks:0cef208aa094b:0-reasons-to-retain-abbott-stock-in-your-portfolio-for-now/", "source_name": "TradingView", "published_at": "2026-07-15T15:37:23", "published_display": "15 Jul 2026 15:37", "sentiment": "positive", "sentiment_pct": 63, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Benchmark reiterates Buy on Abbott Labs stock ahead of Q2 results", "summary": "Benchmark has reiterated a Buy rating and $120 price target for Abbott Laboratories (NYSE:ABT) ahead of its second-quarter 2026 results. The firm projects Q2 revenue of $12.504 billion in constant currency, with significant contributions expected from Diabetes Care and the Exact ", "url": "https://ca.investing.com/news/stock-market-news/benchmark-reiterates-buy-on-abbott-labs-stock-ahead-of-q2-results-93CH-4735619", "source_name": "Investing.com Canada", "published_at": "2026-07-15T14:36:58", "published_display": "15 Jul 2026 14:36", "sentiment": "positive", "sentiment_pct": 70, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Can Abbott (ABT) Turn Freenome Progress Into a Durable Diagnostics-Led Growth Story?", "summary": "Abbott Laboratories is set to release its Q2 2026 results, following advancements in its diagnostics and medical devices portfolio, particularly in cancer screening and diabetes technology. The company's collaboration with Freenome for blood-based colorectal cancer screening is a", "url": "https://simplywall.st/stocks/us/healthcare/nyse-abt/abbott-laboratories/news/can-abbott-abt-turn-freenome-progress-into-a-durable-diagnos/amp", "source_name": "Simply Wall Street", "published_at": "2026-07-15T06:07:03", "published_display": "15 Jul 2026 06:07", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott kept a disciplined manager as pregnant worker's boss, lawsuit alleges", "summary": "A pregnant clinical specialist is suing Abbott Laboratories and St. Jude Medical, alleging she was forced out weeks before her due date after complaining about her supervisor's pregnancy-based comments. Despite the company disciplining the manager for inappropriate remarks, he re", "url": "https://www.hcamag.com/us/specialization/employment-law/abbott-kept-a-disciplined-manager-as-pregnant-workers-boss-lawsuit-alleges/582381", "source_name": "Human Resources Director", "published_at": "2026-07-14T21:57:03", "published_display": "14 Jul 2026 21:57", "sentiment": "negative", "sentiment_pct": 26, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories Stock (ABT) Closed Down by 3.43% on Jul 14: A Full Analysis", "summary": "Abbott Laboratories (ABT) stock declined by 3.43% on July 14, driven by investor concerns over ongoing litigation risks related to infant formula and cautious guidance within its medical devices division. Increased competition and pricing pressures in the continuous glucose monit", "url": "https://www.tradingkey.com/news/market-movers/262029902-market-movers-abt-20260714", "source_name": "TradingKey", "published_at": "2026-07-14T20:37:05", "published_display": "14 Jul 2026 20:37", "sentiment": "negative", "sentiment_pct": 26, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "MedTech stocks lower as HCA surgery volumes dip (HCA:NYSE)", "summary": "MedTech stocks experienced a downturn following HCA Healthcare's announcement of lowered full-year earnings outlook and a preliminary Q2 2026 report indicating a drop in surgical procedures. This decline in surgical volumes at the largest for-profit hospital operator in the U.S. ", "url": "https://seekingalpha.com/news/4613712-medtech-stocks-lower-hca-surgery-volumes-dip", "source_name": "Seeking Alpha", "published_at": "2026-07-14T18:40:39", "published_display": "14 Jul 2026 18:40", "sentiment": "negative", "sentiment_pct": 28, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "sector", "tier_label": "Sector context"}, {"title": "Abbott Laboratories stock underperforms Tuesday when compared to competitors", "summary": "Abbott Laboratories (ABT) stock fell 3.42% on Tuesday, closing at $88.96. This underperformance occurred despite a generally positive day for the stock market, with both the S&P 500 Index and the Dow Jones Industrial Average seeing gains. This marks the fifth consecutive day of l", "url": "https://www.marketwatch.com/data-news/abbott-laboratories-stock-underperforms-tuesday-when-compared-to-competitors-fce21b4d-aacb9f1c7bd5?mod=mw_quote_news", "source_name": "MarketWatch", "published_at": "2026-07-14T16:35:00", "published_display": "14 Jul 2026 16:35", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott's Q2 Earnings on Deck: How Should You Play the Stock Now?", "summary": "Abbott Laboratories (ABT) is set to release its second-quarter 2026 results on July 16, with analysts expecting a 1.6% EPS growth and 12% revenue increase year-over-year. The company's Diagnostics, Established Pharmaceutical Products, and Medical Devices segments are anticipated ", "url": "https://www.tradingview.com/news/zacks:3bed42957094b:0-abbott-s-q2-earnings-on-deck-how-should-you-play-the-stock-now/", "source_name": "TradingView", "published_at": "2026-07-14T13:07:02", "published_display": "14 Jul 2026 13:07", "sentiment": "positive", "sentiment_pct": 63, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories To Go Ex-Dividend On July 15th, 2026 With 0.63 USD Dividend Per Share", "summary": "Abbott Laboratories (NYSE:ABT) is set to go ex-dividend on July 15th, 2026, with a dividend payment of 0.63 USD per share. This information is crucial for investors as it indicates the last day to buy shares to be eligible for the upcoming dividend. The dividend yield and record ", "url": "https://news.futunn.com/en/post/75949666/abbott-laboratories-to-go-ex-dividend-on-july-15th-2026", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-14T09:07:02", "published_display": "14 Jul 2026 09:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rick Larsen makes multiple trades in Abbott Laboratories, Amphenol Corporation and others", "summary": "Rick Larsen, representing Washington's 2nd congressional district, recently executed several investment portfolio transactions as part of an advisor-driven quarterly rebalancing of his Richard R Larsen IRA account. On July 8, 2026, he sold stocks in Abbott Laboratories and S&P Gl", "url": "https://ng.investing.com/news/stock-market-news/rick-larsen-makes-multiple-trades-in-abbott-laboratories-amphenol-corporation-and-others-93CH-2597790", "source_name": "Investing.com Nigeria", "published_at": "2026-07-14T01:53:00", "published_display": "14 Jul 2026 01:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories stock underperforms Monday when compared to competitors", "summary": "Abbott Laboratories (ABT) stock fell by 1.94% on Monday to $92.11, marking its fourth consecutive day of losses. This underperformance occurred during a generally negative trading session, with the S&P 500 Index declining by 0.79% and the Dow Jones Industrial Average falling by 0", "url": "https://www.marketwatch.com/data-news/abbott-laboratories-stock-underperforms-monday-when-compared-to-competitors-62868eee-c14313661e48", "source_name": "MarketWatch", "published_at": "2026-07-13T16:35:00", "published_display": "13 Jul 2026 16:35", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories Q2 2026 Earnings Preview \u2014 July 16, Street Expects $1.28 EPS", "summary": "Wall Street anticipates Abbott Laboratories will report second-quarter 2026 earnings of $1.28 per share on $12.52 billion in revenue, with the consensus reflecting input from 23 analysts. While EPS estimates have stabilized recently, they represent a modest decline from three mon", "url": "https://news.alphastreet.com/abbott-laboratories-q2-2026-earnings-preview-july-16-street-expects-1-28-eps/", "source_name": "AlphaStreet", "published_at": "2026-07-13T11:41:07", "published_display": "13 Jul 2026 11:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tandem Diabetes Care (TNDM) Expands Abbott Compatibility As Undervalued Narrative Faces A Fresh Test", "summary": "Tandem Diabetes Care (TNDM) has announced that its t:slim X2 insulin pump now integrates with Abbott\u2019s FreeStyle Libre 3 Plus CGM in five European countries. Despite this product expansion, the company's share price has experienced recent weakness, leading to a discussion about w", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-tndm/tandem-diabetes-care/news/tandem-diabetes-care-tndm-expands-abbott-compatibility-as-un/amp", "source_name": "Simply Wall Street", "published_at": "2026-07-13T09:09:50", "published_display": "13 Jul 2026 09:09", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Baird Initiates Coverage on Abbott Laboratories (ABT) Stock with Outperform Rating", "summary": "Baird has initiated coverage on Abbott Laboratories (ABT) with an \"Outperform\" rating and a $121.00 price target, expecting steady top-line and earnings growth, especially from its medical device segment. The firm also anticipates new products and the Exact Sciences integration t", "url": "https://finance.yahoo.com/markets/stocks/articles/baird-initiates-coverage-abbott-laboratories-092145070.html", "source_name": "Market source", "published_at": "2026-07-13T09:07:07", "published_display": "13 Jul 2026 09:07", "sentiment": "positive", "sentiment_pct": 67, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Healthcare Stocks: J&J, UnitedHealth, Abbott Face Test on Sector\u2019s 9% Earnings Drop", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNYnFlY0xtUFY4QVFXSFEzQVRZTVRtaVdRaXFUTlJuRk5TX1BhWTlVVU9sU3psYzQwU2haeTN5OFlNTlFzeHZmN05SRlZHNUVfTzc5VjJuRERSMURsU21Qb1NPai1kWU9TVElIb3B0WGZBQnBSSGdVbDR3YWhVcGZnUUs1NC1KMEpKWG5WU3c2bzlvQ19uLTF0ZjF4cGw2cG8?oc=5", "source_name": "TechStock\u00b2", "published_at": "2026-07-12T21:01:30+00:00", "published_display": "12 Jul 2026 21:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories stock holds steady as healthcare demand supports long-term growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQZnNwQzlhdmZFYVIxSGNuMVhzQ1pXc0ZhelVEa1NGcEVuRmdsZkhheW5JaXdsUTdjeVRUZUxLREtpenNlc2VOMlhvTHNrQ1FWYWdmSWZVRFlocmhnT0JwcVBNc2dON2daLU91Q0l3RFE5cVhKMUlVRXNpN29lOEJOY2ZFdUVqT2pkVU9lWTFMSnMzeFJyc2dHQ3pRdVctOGZSc0RUd2E1VzlTVHFXZUMxTDVzYnNEU3d2WkppX3NKaHNaeHNjR2c?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-10T12:57:37+00:00", "published_display": "10 Jul 2026 12:57", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories stock stays supported by diversified health-care business", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQV1ZRbFVoNHVTb3F1eXJXNDRPVHV3SnpRUnJic0JBNXJNMFdvclY4S2hES2lzMVVKeVk3YmJfMHRzcWo5dnZqd3d1UFNwTFRENWFTZDNOcXNHSm5ndkduREl3Y0QzM0c3RDh0RVNqMmsyWHlvQmFyc3ltVzNVdHBDVGx2WWlVVFR4YVpkV2JMQ2VQdV9IS1U5RmRjTEtIV25FbFFUWmk3Vy0yN0d1UmUzaUxCUFNwQURTeDFRUFZVUjEtZGoxeVE?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-09T18:17:42+00:00", "published_display": "09 Jul 2026 18:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Abbott Stock at 52-Week Low After Q1 Earnings: Book Profits or Hold?", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPZ2tDT3NCeW1ncE5vTktLWURiclg3eExyNlJWZHd5Y1hvYzhFZGdObk9XRDdsNzJhWEpvbjBPYXlEbThUc1RjbFpVU0x1UlRkWEN0cmhadWNpVmJ2dXBkLTQtdEdfX1hEdVFxb09Oa3p4RlI0NDNFUFRyNU51RlRsS0hKc2k0N0d0ZjN3WnZFRGhHSk9TNFg4TmdmUGJySXRPb1dEMFhZNXo5d3hGZHdrejM4Wk1IUVQySjN0NUdZcw?oc=5", "source_name": "TradingView", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Abbott (NYSE: ABT) holders back 2026 stock plan, expand board", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQZ3JoYjZxVTNHS1p0SjNCWms3X1FLUEQ1bEkxcXpZaWk4SWpCQW82VWVReWRJUF9YdnA5c3BLV1hmVUVKX25vNlBHcUVsNnNHRVZNN1RrN3l4akFyaXBIQUw4STl0V0NHRTBxY3Uwd19xUkszdzVJLVduVUR6VHZnVnFmUEZRZENCZElkNVRWRVRvUFVVRDZwNDNXUGZHbTBEdk40bkJ4UXhnQWs?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Here Are Wednesday\u2019s Top Wall Street Analyst Research Calls: Abbott Laboratories, Airbnb, Biogen, Cava Group, GitLab, Halliburton, Qualcomm, Seagate, Toast, and More", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAJBVV95cUxOTzVpMFpCWkthZzM5LVdYMTFiRDIzVFhteFl4d0RVVlNlWkVZN09YdDJ2N3lSbjkxTE9DYjMxcjJ2SHpkWmYwOWhVQThNS0VReUNIa3BJS2p4WUFOc2JqNE5qZkxERXhiTGpBSFkxQm1LLUc2US1QOGY2bC1mbndPS3Q3d1dzdzVGYVQwUk90WTQxOHVUWU1KMlFaVWtXTm9SdWk1MjU2a1BCdzR1MzAxaUdGYVZMOHY1TVFQZnFOMDNrZDd6anItOVFSeUM3bFpLWEt0dzdRcDRxWkVqNkxOTTZpaWlZc05zQlhvVEIyVnR6NkJiX0NtWWgtd1NtQ3hVa19BeUVxVXI1VF9JYU1UTUhaT3Z4SFNaa3ZTM0ZNR1Z1d2pr?oc=5", "source_name": "24/7 Wall St.", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOc2thQjFpazgwaFRfS3NjVXhlTkdFWHNFb240S0Z6akFtQXFIMmFmaXZnQ1A3OFVCQW9DT25OLVBQdGN5Yk52Mk9yUFlSX19ZS3FRTjZoR05zc2FVc25pVHQ0TDVHT2JmVnJabGNCREdLT2stV0IzLVdHWXpFZGU3V1NnVGhYbFRzNURVek41TVRmLWZQZTFYUkc4aXM0a1cwTkNFYTBfVnQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories (ABT) Margin Drop To 13.9% Challenges Bullish Earnings Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-18T07:00:00+00:00", "published_display": "18 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[8-K] ABBOTT LABORATORIES Reports Material Event", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxOb0hjR3lyMkNadi1UdXpSNlNLSENuMW5rYk1zdGZ6aXNWVjVXU0JQSVhrWndBc3gzX3RMQ2s1SEltWE9Yb2RWUW1yUFdyNUcxcjI1VjlrNWpvOV9obEcyQzJQSTBRSnI4czVNT2h4QlQ3R1F1ell0Yjh3T3YwMGNZWHJNWUxIcVdnU3RmUG0zLS1ZYXJtWE94N2UydDgyWGFGZE83LWc3MHItMU0?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories Insiders Added US$3.10m Of Stock To Their Holdings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxPam5FTVFINjFzRXJNRXc1UUxLZUtBVTR6TXJRZUh3MXlxYnRFUno1T1UtQl83RVUyeDlBVTB2YURVQndvYnhOVW5WTG93c0lZXzRaSWEtTXRLT2tuOVpyaTVRTU5uaElPT2RzRGJxdzRLcEUyMzFZS1BFZVFwel80UDZ3Q2tUQXJfSG5F?oc=5", "source_name": "Market source", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories price faces negative outlook - Forecast today - 10-04-2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxPM0t1clVYel8yb09XZGNZd1hMalhOX3dTYjI1SnhDVS0wajloX2I3T2tKeUtycWY4cTBHSkVZdXBmX01Ma0hEcVFtVURySkFvODhNTWIwdUlnSkI2V05rRDdrR3JQa0dYVFpNZ1Nsb05TdkNHejhGNFdEU1Zrbzd3SlFCVEZfZG5YU0pKN0FfRnpoR3M3VkM3a25udl9ZY282dkZVQXROdWVvalZ0UVlycjBSV3RlSFhJOXRobkNxc1M2ZDFyWEJveFprVXhPTTl0NC1yYm1wdkU?oc=5", "source_name": "Economies.com", "published_at": "2026-04-10T07:00:00+00:00", "published_display": "10 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Reasons to Retain Abbott Stock in Your Portfolio Now", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPUDZkXzk5d3RaQ1RKYlBVRjVfRW9WZm1HbllELV82TGVyLUcwOEZQOFdXMG1PSnU1Sk1qdmdwcWEySzY0elZjWlNxZFF6NmpMMjN6b09UY1lyTE95ZGNnNFgtQ20zSlJSeGdFX2MwT1plNGxTdXlERWpfZDNwdGRjOHA2RDZUX1hTa19iM25qQzAtd3I0Tm1hNndYNWhPcGZNSENxOWN4dlpMODlV?oc=5", "source_name": "TradingView", "published_at": "2026-04-01T07:00:00+00:00", "published_display": "01 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Abbott Labs Q4 2025: Revenue Miss, Device Growth & Exact Sciences Acquisition - News and Statistics", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQR3R4V19DdlJINXJqRy1WQjhKTm4tck5oT1FOc1pYbjNCQUdXY1RLQmtoa21JQzVmRU95eUJQZDJjZjJudURxQlEyd2FkT0Zhckc3M2FLVjd6OU1ZSy02cE1nT25wNzdTRF9uNE43SmFuRGtNWHJ4SEhQalVCTXRBek55UkVGTWtYQW02bXVuenRxY0NaY0g2bXdrbGdHZEZaMTJKazBRMFkzb3pp?oc=5", "source_name": "IndexBox", "published_at": "2026-03-19T07:00:00+00:00", "published_display": "19 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "by_tier": {"direct": [{"title": "Abbott stock powers through 100-DMA, but long-term downtrend still looms (ABT:NYSE)", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQSGxrSDZvMDVHSkxRYlZBOTFsVk9lY1M5M0xFM1dJVTgtWXBJU2Q1azAyeW5TcUVzelg3LUNwOWR1Wkl5Z0hfVUZFWnY3bW5wNlJiSnJHUV9VVTNSR09OYU5wZTRnVFUtVWpfTnhqdFVadThEdEFuV1JDcmxXZXc2ckpHMU1GVW94Y1RvYzM5NlgtODc2UGNJeVVNWkNRWHNFYV82QmdXZ09vbV96WGc?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-16T16:51:30+00:00", "published_display": "16 Jul 2026 16:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott (ABT) Shares Rise 10.7%", "summary": "", "url": "https://news.google.com/rss/articles/CBMic0FVX3lxTFA4ZlBHYWgwSllfcDZQdjhCMnN0bW9YMmtIeWQ4bHJ3VVEzSUgxWlh4TmFNVnlscktjMWJKNy04dGU4YkttRkFjRjQyZjVKWWdNbFE0d3kzWGZVS3FKY1hvcElNNHMzeldxX0lBS1Z5U2hwQlE?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-16T16:45:34+00:00", "published_display": "16 Jul 2026 16:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories Stock (ABT) Rallies on a Q2 Earnings Beat and a 2026 EPS Guidance Increase", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPa3c2bjJkZEtrNF82Tl9HLTRpM0pWNExtNjBKOUgxRTY1dm5KbTR0a3J4UFdOeFBBWDlwVG9jUDdZdGNSb19FSzMxbG4zSjN0Q29Ta3JWanRNR25rSXNWZnlWdGNpVm4zMGxsbE5JSUJ3WXJGWS1XcmFDQkdPanFPUVMwUlo1MXZLTWJ4SFA5TFN3bi12MC1OOS11cmtLUTNWMGNyajFobTdOWWF5X1NZNDFSNmRaWjV1SlZ5Q3RYaw?oc=5", "source_name": "TipRanks", "published_at": "2026-07-16T16:36:28+00:00", "published_display": "16 Jul 2026 16:36", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories shares jump as earnings beat estimates and company raises 2026 outlook", "summary": "", "url": "https://finance.yahoo.com/m/84518966-d2b7-301d-86f8-a7605f549215/abbott-laboratories-shares.html", "source_name": "Proactive", "published_at": "2026-07-16T16:23:00+00:00", "published_display": "16 Jul 2026 16:23", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stock Market Today: Nasdaq Slides While TSMC Hits Sell Rule; Abbott Soars (Live Coverage)", "summary": "", "url": "https://finance.yahoo.com/m/c5561775-6f2a-30c3-8319-d6feaa5d3578/stock-market-today%3A-nasdaq.html", "source_name": "Investor's Business Daily", "published_at": "2026-07-16T16:08:01+00:00", "published_display": "16 Jul 2026 16:08", "sentiment": "negative", "sentiment_pct": 42, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stocks making the biggest moves midday: Manpower, Abbott, UnitedHealth, TSMC & more", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxPaUJKazRxOGhsbTJBaDB2ZkhVa2k1cDFIdTZtc1hnMWNNbjJRRzFRSmxyNkM1SFRMdVVDSlMyT1hrQW9BN09Qd3BPTXl3LXlmOEZyNmsxaFFETVB0eTVYRGsyNVd2bzlVeUpRcURIQjBBSC04aU1XQlB4TkNDMS1XR0hjeXRfbGpZNzczTG92NUZrYjZ5VktfOUNoeXY?oc=5", "source_name": "CNBC", "published_at": "2026-07-16T16:03:48+00:00", "published_display": "16 Jul 2026 16:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Q2 Earnings & Revenues Top Estimates, Stock Up in Pre-market", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/abbott-q2-earnings-revenues-top-155000355.html", "source_name": "Zacks", "published_at": "2026-07-16T15:50:00+00:00", "published_display": "16 Jul 2026 15:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Abbott Stock Is Having Its Best Day in 24 Years", "summary": "", "url": "https://finance.yahoo.com/m/70706931-299d-39fa-826f-4e8791c41c0c/why-abbott-stock-is-having.html", "source_name": "Barrons.com", "published_at": "2026-07-16T15:48:00+00:00", "published_display": "16 Jul 2026 15:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Stock Is Leading the S&P 500 After Earnings for Its Best Day in 24 Years", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE9nWkpfejFEQ0ozN0taTzJ5ZTRnWUVtUjUzZDJ5MEZKZnphQ1ZJaGlxMDhGMENWb3lWM3dKcWIzTWhKVE1JWXM4Z0Z3eGVrUVo5NjBNX0Y5OVc0UkVVZU1fLThrazZiQnRRS0lqbG1kWkQ4LXRxcUw0Xw?oc=5", "source_name": "Barron's", "published_at": "2026-07-16T15:48:00+00:00", "published_display": "16 Jul 2026 15:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories: Double Beat And Raise Surprises The Street (Rating Upgrade) (ABT)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxQbVJxakpNQ3hMemFxYjRCdjFTUGlpMGRpN0F5U1o4Q0M3TlJISDhXMzFHTDBPclk2aF9uWUVmNGpkOXRZTWxOZWpqSEV1cG1xbHktSW4tc2VpMXZVWi1vS1UyTTAwTGN0UnVBOGt5X2M2c3VUSXE4QXhzdi1VRU1WY0l4ay1zTktuTXpSalM3N3BCTGoyTkFCbmxqeFIyb2FnaHRQRDBuYWdaUVRzWm1CZVB4YWQ3YzA4SHJNWUVkVmh4aHBGQXlTMnhCN3lPZW5VRkM4?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-16T15:46:22+00:00", "published_display": "16 Jul 2026 15:46", "sentiment": "positive", "sentiment_pct": 95, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories Q2 Earnings Call Highlights", "summary": "", "url": "https://finance.yahoo.com/m/f558be41-72a2-3ca2-bc1a-1d4232b60495/abbott-laboratories-q2.html", "source_name": "MarketBeat", "published_at": "2026-07-16T15:04:48+00:00", "published_display": "16 Jul 2026 15:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott (ABT) Sees Significant Stock Surge of 12.5%", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOGI5YlV1YU5sTE05Z0lPZktQX244TTRldWZ6ZGU4UTllRGtkMTJ5dDA4d01QLVZVQ2xES2JINkh0N0hmVlJaY1lMU1FQRGRoaV82bW9sUUNWRzcyNzVBc2JSX3k0cVpiR1R3eThtZnc2WjFqUGItOHJJM1U5SXJYVloxeDhVM1lJLWgtWVBn?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-16T14:49:03+00:00", "published_display": "16 Jul 2026 14:49", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Stock Soars 13% On Earnings Beat, Guidance Raise - Abbott Laboratories (NYSE:ABT)", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxQTTQzNUdJdGFUc3h0Rmlnb2FlcmJ0ZEU5dHF2VFBEelBObW43QTFleVBhV0F4YUp2QlRSdkpVUEpHU0paNGxZcFk2Um03NWlRY1dSWmh3VVFMSkYwTjdMWHh6N2ZNMC0zMG9uMkFqb205U19lTlhwWmJiZ1FrSG9BSi13SUNkMGZaeWhJXzI5cmVObjJVNnNtbFdNa0w2dmUxUkR6SmlacC1mXzRObmg0YzE1SV8?oc=5", "source_name": "Benzinga", "published_at": "2026-07-16T14:45:35+00:00", "published_display": "16 Jul 2026 14:45", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories Raises Full-Year Earnings Guidance as Second-Quarter Results Top Views", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/abbott-laboratories-raises-full-earnings-143219434.html", "source_name": "MT Newswires", "published_at": "2026-07-16T14:32:19+00:00", "published_display": "16 Jul 2026 14:32", "sentiment": "positive", "sentiment_pct": 58, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott, Up 14%, Strikes Three-Month High After Boosting 2026 Profit Outlook", "summary": "", "url": "https://finance.yahoo.com/m/91665efd-7328-3275-ad41-358ac40e9854/abbott%2C-up-14%25%2C-strikes.html", "source_name": "Investor's Business Daily", "published_at": "2026-07-16T14:22:04+00:00", "published_display": "16 Jul 2026 14:22", "sentiment": "positive", "sentiment_pct": 58, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Abbott Stock Is Reimagining Its Future", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNSk5SNVotQmFsQTU5bnBOcG1wSmtvcDI4Q0lEZUJ1eU9YSUtlVTJ5TVBGT29Obl81a19DLVIxdXVsVHBsR3lzdjFkdGt6Yjc5QzNLN3Ewa3VDcHJVbXVIZ2h2VFMyeGVuNWVHZE1FQngteEMzNU0ycHB1UWhJZ2RQOXdYSUQ5elU3S1FvUXFwV1BNdUo1WUV0TGRoRk5YTXNqRXNJVg?oc=5", "source_name": "Trefis", "published_at": "2026-07-16T14:07:55+00:00", "published_display": "16 Jul 2026 14:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott raises 2026 earnings outlook after second-quarter results beat expectations (ABT)", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxPTWVlcHQyeTR0aWE2TnFnX05oWVA3ZWRDWk80UHJGTm5sNDJkSGF3dTdDRlVBMnZKaTIwYXpFWk5SbVNzWGVublFyZlBlSjZIQW5OcnBPNFZPbGtGVnRLbFNIaFRhaTduZ0Uxd1RaN2V5RkdhX0FlcWFsSFVFR1ZDcGZhQ1hNcE1QV1RYTmd2UTBzRF9LLWJRVWpsR0I?oc=5", "source_name": "Market source", "published_at": "2026-07-16T12:43:10+00:00", "published_display": "16 Jul 2026 12:43", "sentiment": "positive", "sentiment_pct": 95, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott rises as guidance hike tops expectations (ABT:NYSE)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxNY1ZVekxEbHNpT3hrcUlBaUlyV09wVmwySGl4NTB6Rnk0ZllYN1prbWhjV1gzaHhQNWdXX1dlYlZva2xWcFpGaTRHQjNCM3BGU1NBWWduUlk2Q1FTVzZIXzgtbERucUJtMnVMeUI0WjZtQmZhNXZfVkNkZG5aYWo3b1NuTUFJTEk1OEE?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-16T12:39:07+00:00", "published_display": "16 Jul 2026 12:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories NYSE:ABT Rises on In-Line Q2 and Raised Guidance", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQbEc5NmplWklTZ3ZuMlMyUTI2MzJxdDZiREF4dzRDSDM4TlBLcnRjWm9OSmNwMDlJS0U1UWp2SWhIb3FIYW9qNVRPTFNjR0RXVk10b1kxNkx5MnJTN1RRWmZSRU9weU91OVFzZ0pXTTVEWmVJM2dhVjJVaWNmelJrUDBobF80R0QwZzdMOU1JaERWSnAyeDQtY19HZDFEcEVUMTZnNFMxSkJzM0lsNG9xQW0zLXZ5aWNkaVE?oc=5", "source_name": "ChartMill", "published_at": "2026-07-16T12:20:15+00:00", "published_display": "16 Jul 2026 12:20", "sentiment": "positive", "sentiment_pct": 68, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Abbott Laboratories (ABT) Below Fair Value After Its 31% Fall?", "summary": "Abbott Laboratories (ABT) has experienced a 31% stock price fall over the past year, leading to investor sentiment turning negative. However, both discounted cash flow (DCF) analysis and traditional market multiples suggest the shares are currently trading at a discount. Despite ", "url": "https://finance.yahoo.com/markets/stocks/articles/abbott-laboratories-abt-below-fair-131308260.html", "source_name": "Market source", "published_at": "2026-07-16T13:12:59", "published_display": "16 Jul 2026 13:12", "sentiment": "positive", "sentiment_pct": 70, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ABBOTT LABORATORIES ($ABT) Releases Q2 2026 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxOU1gtODRaaExTNkxwWl9nQzh1OTJ5NlhtWGtUd3lwMnVldWU2RzJoNG5LX3ZNOGNIcW1Ra0cwZHdDemFsTWhQeldkZFZ0em1EUDY2ZV9SejdnbnRfR2RFWFdSNkdGcGVwOWV5SHVCdTRHb005enVSUHY5ekpSTFJBUmRzeC1Bck96Qm9KY2Z2ZnhqV0Znc0E?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-16T11:55:00+00:00", "published_display": "16 Jul 2026 11:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Boosts 2026 Profit Guidance as Sales Across Business Rise", "summary": "Abbott Laboratories has increased its 2026 profit guidance following a better-than-expected second quarter. The company now anticipates adjusted earnings per share to be between $5.45 and $5.60, representing a 5-cent improvement at the midpoint. This positive outlook is attribute", "url": "https://www.bloomberg.com/news/articles/2026-07-16/abbott-boosts-2026-profit-guidance-as-sales-across-business-rise", "source_name": "Bloomberg.com", "published_at": "2026-07-16T11:42:09", "published_display": "16 Jul 2026 11:42", "sentiment": "positive", "sentiment_pct": 80, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance", "summary": "Abbott announced its second-quarter 2026 financial results, reporting a 13.0% increase in sales and a 4.8% comparable sales growth. The company also raised its full-year 2026 adjusted diluted EPS guidance to $5.45 to $5.60, up from the previous range of $5.38 to $5.58. Key busine", "url": "https://www.prnewswire.com/news-releases/abbott-reports-second-quarter-2026-results-and-raises-full-year-eps-guidance-302827508.html", "source_name": "PR Newswire", "published_at": "2026-07-16T11:29:57", "published_display": "16 Jul 2026 11:29", "sentiment": "positive", "sentiment_pct": 73, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Employees sue medical giant over excessive healthcare costs", "summary": "A group of Abbott Laboratories employees has filed a class-action lawsuit alleging they were overcharged for health insurance plans that offered no additional benefits. The suit claims Abbott offered two plans with the same medical coverage but different costs, violating the Empl", "url": "https://www.courthousenews.com/employees-sue-medical-giant-over-excessive-healthcare-costs/", "source_name": "Courthouse News", "published_at": "2026-07-15T17:35:03", "published_display": "15 Jul 2026 17:35", "sentiment": "negative", "sentiment_pct": 30, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reasons to Retain Abbott Stock in Your Portfolio for Now", "summary": "Abbott Laboratories (ABT) is recommended as a stock to retain due to strong performance in its Nutrition business and growth in emerging markets within its Established Pharmaceuticals Division (EPD). However, potential headwinds include currency fluctuations, a dull macroeconomic", "url": "https://www.tradingview.com/news/zacks:0cef208aa094b:0-reasons-to-retain-abbott-stock-in-your-portfolio-for-now/", "source_name": "TradingView", "published_at": "2026-07-15T15:37:23", "published_display": "15 Jul 2026 15:37", "sentiment": "positive", "sentiment_pct": 63, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Benchmark reiterates Buy on Abbott Labs stock ahead of Q2 results", "summary": "Benchmark has reiterated a Buy rating and $120 price target for Abbott Laboratories (NYSE:ABT) ahead of its second-quarter 2026 results. The firm projects Q2 revenue of $12.504 billion in constant currency, with significant contributions expected from Diabetes Care and the Exact ", "url": "https://ca.investing.com/news/stock-market-news/benchmark-reiterates-buy-on-abbott-labs-stock-ahead-of-q2-results-93CH-4735619", "source_name": "Investing.com Canada", "published_at": "2026-07-15T14:36:58", "published_display": "15 Jul 2026 14:36", "sentiment": "positive", "sentiment_pct": 70, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Can Abbott (ABT) Turn Freenome Progress Into a Durable Diagnostics-Led Growth Story?", "summary": "Abbott Laboratories is set to release its Q2 2026 results, following advancements in its diagnostics and medical devices portfolio, particularly in cancer screening and diabetes technology. The company's collaboration with Freenome for blood-based colorectal cancer screening is a", "url": "https://simplywall.st/stocks/us/healthcare/nyse-abt/abbott-laboratories/news/can-abbott-abt-turn-freenome-progress-into-a-durable-diagnos/amp", "source_name": "Simply Wall Street", "published_at": "2026-07-15T06:07:03", "published_display": "15 Jul 2026 06:07", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott kept a disciplined manager as pregnant worker's boss, lawsuit alleges", "summary": "A pregnant clinical specialist is suing Abbott Laboratories and St. Jude Medical, alleging she was forced out weeks before her due date after complaining about her supervisor's pregnancy-based comments. Despite the company disciplining the manager for inappropriate remarks, he re", "url": "https://www.hcamag.com/us/specialization/employment-law/abbott-kept-a-disciplined-manager-as-pregnant-workers-boss-lawsuit-alleges/582381", "source_name": "Human Resources Director", "published_at": "2026-07-14T21:57:03", "published_display": "14 Jul 2026 21:57", "sentiment": "negative", "sentiment_pct": 26, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories Stock (ABT) Closed Down by 3.43% on Jul 14: A Full Analysis", "summary": "Abbott Laboratories (ABT) stock declined by 3.43% on July 14, driven by investor concerns over ongoing litigation risks related to infant formula and cautious guidance within its medical devices division. Increased competition and pricing pressures in the continuous glucose monit", "url": "https://www.tradingkey.com/news/market-movers/262029902-market-movers-abt-20260714", "source_name": "TradingKey", "published_at": "2026-07-14T20:37:05", "published_display": "14 Jul 2026 20:37", "sentiment": "negative", "sentiment_pct": 26, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories stock underperforms Tuesday when compared to competitors", "summary": "Abbott Laboratories (ABT) stock fell 3.42% on Tuesday, closing at $88.96. This underperformance occurred despite a generally positive day for the stock market, with both the S&P 500 Index and the Dow Jones Industrial Average seeing gains. This marks the fifth consecutive day of l", "url": "https://www.marketwatch.com/data-news/abbott-laboratories-stock-underperforms-tuesday-when-compared-to-competitors-fce21b4d-aacb9f1c7bd5?mod=mw_quote_news", "source_name": "MarketWatch", "published_at": "2026-07-14T16:35:00", "published_display": "14 Jul 2026 16:35", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott's Q2 Earnings on Deck: How Should You Play the Stock Now?", "summary": "Abbott Laboratories (ABT) is set to release its second-quarter 2026 results on July 16, with analysts expecting a 1.6% EPS growth and 12% revenue increase year-over-year. The company's Diagnostics, Established Pharmaceutical Products, and Medical Devices segments are anticipated ", "url": "https://www.tradingview.com/news/zacks:3bed42957094b:0-abbott-s-q2-earnings-on-deck-how-should-you-play-the-stock-now/", "source_name": "TradingView", "published_at": "2026-07-14T13:07:02", "published_display": "14 Jul 2026 13:07", "sentiment": "positive", "sentiment_pct": 63, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories To Go Ex-Dividend On July 15th, 2026 With 0.63 USD Dividend Per Share", "summary": "Abbott Laboratories (NYSE:ABT) is set to go ex-dividend on July 15th, 2026, with a dividend payment of 0.63 USD per share. This information is crucial for investors as it indicates the last day to buy shares to be eligible for the upcoming dividend. The dividend yield and record ", "url": "https://news.futunn.com/en/post/75949666/abbott-laboratories-to-go-ex-dividend-on-july-15th-2026", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-14T09:07:02", "published_display": "14 Jul 2026 09:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rick Larsen makes multiple trades in Abbott Laboratories, Amphenol Corporation and others", "summary": "Rick Larsen, representing Washington's 2nd congressional district, recently executed several investment portfolio transactions as part of an advisor-driven quarterly rebalancing of his Richard R Larsen IRA account. On July 8, 2026, he sold stocks in Abbott Laboratories and S&P Gl", "url": "https://ng.investing.com/news/stock-market-news/rick-larsen-makes-multiple-trades-in-abbott-laboratories-amphenol-corporation-and-others-93CH-2597790", "source_name": "Investing.com Nigeria", "published_at": "2026-07-14T01:53:00", "published_display": "14 Jul 2026 01:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories stock underperforms Monday when compared to competitors", "summary": "Abbott Laboratories (ABT) stock fell by 1.94% on Monday to $92.11, marking its fourth consecutive day of losses. This underperformance occurred during a generally negative trading session, with the S&P 500 Index declining by 0.79% and the Dow Jones Industrial Average falling by 0", "url": "https://www.marketwatch.com/data-news/abbott-laboratories-stock-underperforms-monday-when-compared-to-competitors-62868eee-c14313661e48", "source_name": "MarketWatch", "published_at": "2026-07-13T16:35:00", "published_display": "13 Jul 2026 16:35", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories Q2 2026 Earnings Preview \u2014 July 16, Street Expects $1.28 EPS", "summary": "Wall Street anticipates Abbott Laboratories will report second-quarter 2026 earnings of $1.28 per share on $12.52 billion in revenue, with the consensus reflecting input from 23 analysts. While EPS estimates have stabilized recently, they represent a modest decline from three mon", "url": "https://news.alphastreet.com/abbott-laboratories-q2-2026-earnings-preview-july-16-street-expects-1-28-eps/", "source_name": "AlphaStreet", "published_at": "2026-07-13T11:41:07", "published_display": "13 Jul 2026 11:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tandem Diabetes Care (TNDM) Expands Abbott Compatibility As Undervalued Narrative Faces A Fresh Test", "summary": "Tandem Diabetes Care (TNDM) has announced that its t:slim X2 insulin pump now integrates with Abbott\u2019s FreeStyle Libre 3 Plus CGM in five European countries. Despite this product expansion, the company's share price has experienced recent weakness, leading to a discussion about w", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-tndm/tandem-diabetes-care/news/tandem-diabetes-care-tndm-expands-abbott-compatibility-as-un/amp", "source_name": "Simply Wall Street", "published_at": "2026-07-13T09:09:50", "published_display": "13 Jul 2026 09:09", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Baird Initiates Coverage on Abbott Laboratories (ABT) Stock with Outperform Rating", "summary": "Baird has initiated coverage on Abbott Laboratories (ABT) with an \"Outperform\" rating and a $121.00 price target, expecting steady top-line and earnings growth, especially from its medical device segment. The firm also anticipates new products and the Exact Sciences integration t", "url": "https://finance.yahoo.com/markets/stocks/articles/baird-initiates-coverage-abbott-laboratories-092145070.html", "source_name": "Market source", "published_at": "2026-07-13T09:07:07", "published_display": "13 Jul 2026 09:07", "sentiment": "positive", "sentiment_pct": 67, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Healthcare Stocks: J&J, UnitedHealth, Abbott Face Test on Sector\u2019s 9% Earnings Drop", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNYnFlY0xtUFY4QVFXSFEzQVRZTVRtaVdRaXFUTlJuRk5TX1BhWTlVVU9sU3psYzQwU2haeTN5OFlNTlFzeHZmN05SRlZHNUVfTzc5VjJuRERSMURsU21Qb1NPai1kWU9TVElIb3B0WGZBQnBSSGdVbDR3YWhVcGZnUUs1NC1KMEpKWG5WU3c2bzlvQ19uLTF0ZjF4cGw2cG8?oc=5", "source_name": "TechStock\u00b2", "published_at": "2026-07-12T21:01:30+00:00", "published_display": "12 Jul 2026 21:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories stock holds steady as healthcare demand supports long-term growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQZnNwQzlhdmZFYVIxSGNuMVhzQ1pXc0ZhelVEa1NGcEVuRmdsZkhheW5JaXdsUTdjeVRUZUxLREtpenNlc2VOMlhvTHNrQ1FWYWdmSWZVRFlocmhnT0JwcVBNc2dON2daLU91Q0l3RFE5cVhKMUlVRXNpN29lOEJOY2ZFdUVqT2pkVU9lWTFMSnMzeFJyc2dHQ3pRdVctOGZSc0RUd2E1VzlTVHFXZUMxTDVzYnNEU3d2WkppX3NKaHNaeHNjR2c?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-10T12:57:37+00:00", "published_display": "10 Jul 2026 12:57", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories stock stays supported by diversified health-care business", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQV1ZRbFVoNHVTb3F1eXJXNDRPVHV3SnpRUnJic0JBNXJNMFdvclY4S2hES2lzMVVKeVk3YmJfMHRzcWo5dnZqd3d1UFNwTFRENWFTZDNOcXNHSm5ndkduREl3Y0QzM0c3RDh0RVNqMmsyWHlvQmFyc3ltVzNVdHBDVGx2WWlVVFR4YVpkV2JMQ2VQdV9IS1U5RmRjTEtIV25FbFFUWmk3Vy0yN0d1UmUzaUxCUFNwQURTeDFRUFZVUjEtZGoxeVE?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-09T18:17:42+00:00", "published_display": "09 Jul 2026 18:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Stock at 52-Week Low After Q1 Earnings: Book Profits or Hold?", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPZ2tDT3NCeW1ncE5vTktLWURiclg3eExyNlJWZHd5Y1hvYzhFZGdObk9XRDdsNzJhWEpvbjBPYXlEbThUc1RjbFpVU0x1UlRkWEN0cmhadWNpVmJ2dXBkLTQtdEdfX1hEdVFxb09Oa3p4RlI0NDNFUFRyNU51RlRsS0hKc2k0N0d0ZjN3WnZFRGhHSk9TNFg4TmdmUGJySXRPb1dEMFhZNXo5d3hGZHdrejM4Wk1IUVQySjN0NUdZcw?oc=5", "source_name": "TradingView", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott (NYSE: ABT) holders back 2026 stock plan, expand board", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQZ3JoYjZxVTNHS1p0SjNCWms3X1FLUEQ1bEkxcXpZaWk4SWpCQW82VWVReWRJUF9YdnA5c3BLV1hmVUVKX25vNlBHcUVsNnNHRVZNN1RrN3l4akFyaXBIQUw4STl0V0NHRTBxY3Uwd19xUkszdzVJLVduVUR6VHZnVnFmUEZRZENCZElkNVRWRVRvUFVVRDZwNDNXUGZHbTBEdk40bkJ4UXhnQWs?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here Are Wednesday\u2019s Top Wall Street Analyst Research Calls: Abbott Laboratories, Airbnb, Biogen, Cava Group, GitLab, Halliburton, Qualcomm, Seagate, Toast, and More", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAJBVV95cUxOTzVpMFpCWkthZzM5LVdYMTFiRDIzVFhteFl4d0RVVlNlWkVZN09YdDJ2N3lSbjkxTE9DYjMxcjJ2SHpkWmYwOWhVQThNS0VReUNIa3BJS2p4WUFOc2JqNE5qZkxERXhiTGpBSFkxQm1LLUc2US1QOGY2bC1mbndPS3Q3d1dzdzVGYVQwUk90WTQxOHVUWU1KMlFaVWtXTm9SdWk1MjU2a1BCdzR1MzAxaUdGYVZMOHY1TVFQZnFOMDNrZDd6anItOVFSeUM3bFpLWEt0dzdRcDRxWkVqNkxOTTZpaWlZc05zQlhvVEIyVnR6NkJiX0NtWWgtd1NtQ3hVa19BeUVxVXI1VF9JYU1UTUhaT3Z4SFNaa3ZTM0ZNR1Z1d2pr?oc=5", "source_name": "24/7 Wall St.", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOc2thQjFpazgwaFRfS3NjVXhlTkdFWHNFb240S0Z6akFtQXFIMmFmaXZnQ1A3OFVCQW9DT25OLVBQdGN5Yk52Mk9yUFlSX19ZS3FRTjZoR05zc2FVc25pVHQ0TDVHT2JmVnJabGNCREdLT2stV0IzLVdHWXpFZGU3V1NnVGhYbFRzNURVek41TVRmLWZQZTFYUkc4aXM0a1cwTkNFYTBfVnQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories (ABT) Margin Drop To 13.9% Challenges Bullish Earnings Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-18T07:00:00+00:00", "published_display": "18 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[8-K] ABBOTT LABORATORIES Reports Material Event", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxOb0hjR3lyMkNadi1UdXpSNlNLSENuMW5rYk1zdGZ6aXNWVjVXU0JQSVhrWndBc3gzX3RMQ2s1SEltWE9Yb2RWUW1yUFdyNUcxcjI1VjlrNWpvOV9obEcyQzJQSTBRSnI4czVNT2h4QlQ3R1F1ell0Yjh3T3YwMGNZWHJNWUxIcVdnU3RmUG0zLS1ZYXJtWE94N2UydDgyWGFGZE83LWc3MHItMU0?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories Insiders Added US$3.10m Of Stock To Their Holdings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxPam5FTVFINjFzRXJNRXc1UUxLZUtBVTR6TXJRZUh3MXlxYnRFUno1T1UtQl83RVUyeDlBVTB2YURVQndvYnhOVW5WTG93c0lZXzRaSWEtTXRLT2tuOVpyaTVRTU5uaElPT2RzRGJxdzRLcEUyMzFZS1BFZVFwel80UDZ3Q2tUQXJfSG5F?oc=5", "source_name": "Market source", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories price faces negative outlook - Forecast today - 10-04-2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxPM0t1clVYel8yb09XZGNZd1hMalhOX3dTYjI1SnhDVS0wajloX2I3T2tKeUtycWY4cTBHSkVZdXBmX01Ma0hEcVFtVURySkFvODhNTWIwdUlnSkI2V05rRDdrR3JQa0dYVFpNZ1Nsb05TdkNHejhGNFdEU1Zrbzd3SlFCVEZfZG5YU0pKN0FfRnpoR3M3VkM3a25udl9ZY282dkZVQXROdWVvalZ0UVlycjBSV3RlSFhJOXRobkNxc1M2ZDFyWEJveFprVXhPTTl0NC1yYm1wdkU?oc=5", "source_name": "Economies.com", "published_at": "2026-04-10T07:00:00+00:00", "published_display": "10 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reasons to Retain Abbott Stock in Your Portfolio Now", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPUDZkXzk5d3RaQ1RKYlBVRjVfRW9WZm1HbllELV82TGVyLUcwOEZQOFdXMG1PSnU1Sk1qdmdwcWEySzY0elZjWlNxZFF6NmpMMjN6b09UY1lyTE95ZGNnNFgtQ20zSlJSeGdFX2MwT1plNGxTdXlERWpfZDNwdGRjOHA2RDZUX1hTa19iM25qQzAtd3I0Tm1hNndYNWhPcGZNSENxOWN4dlpMODlV?oc=5", "source_name": "TradingView", "published_at": "2026-04-01T07:00:00+00:00", "published_display": "01 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Labs Q4 2025: Revenue Miss, Device Growth & Exact Sciences Acquisition - News and Statistics", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQR3R4V19DdlJINXJqRy1WQjhKTm4tck5oT1FOc1pYbjNCQUdXY1RLQmtoa21JQzVmRU95eUJQZDJjZjJudURxQlEyd2FkT0Zhckc3M2FLVjd6OU1ZSy02cE1nT25wNzdTRF9uNE43SmFuRGtNWHJ4SEhQalVCTXRBek55UkVGTWtYQW02bXVuenRxY0NaY0g2bXdrbGdHZEZaMTJKazBRMFkzb3pp?oc=5", "source_name": "IndexBox", "published_at": "2026-03-19T07:00:00+00:00", "published_display": "19 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": [{"title": "MedTech stocks lower as HCA surgery volumes dip (HCA:NYSE)", "summary": "MedTech stocks experienced a downturn following HCA Healthcare's announcement of lowered full-year earnings outlook and a preliminary Q2 2026 report indicating a drop in surgical procedures. This decline in surgical volumes at the largest for-profit hospital operator in the U.S. ", "url": "https://seekingalpha.com/news/4613712-medtech-stocks-lower-hca-surgery-volumes-dip", "source_name": "Seeking Alpha", "published_at": "2026-07-14T18:40:39", "published_display": "14 Jul 2026 18:40", "sentiment": "negative", "sentiment_pct": 28, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "sector", "tier_label": "Sector context"}]}, "total_fetched": 109, "total_relevant": 66, "sentiment_summary": {"positive": 21, "negative": 8, "neutral": 37, "score": 55, "total": 66, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "earnings", "primary_label": "Earnings", "confidence": 77, "events": [{"event": "earnings", "label": "Earnings", "weight": 18.53, "count": 34}, {"event": "general", "label": "Market update", "weight": 11.1, "count": 17}, {"event": "guidance", "label": "Guidance", "weight": 2.55, "count": 4}, {"event": "analyst", "label": "Analyst action", "weight": 2.0, "count": 3}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.1, "count": 2}, {"event": "macro", "label": "Macro sensitivity", "weight": 1.1, "count": 2}], "positive_events": 21, "negative_events": 8}, "market_context": {"has_market_context": true, "latest_close": 93.93, "latest_week": "2026-07-10", "one_week_move": -1.5, "four_week_move": 6.5, "twelve_week_move": -3.0, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.416069, "market_dynamics_buy_signal": false, "relative_strength": -25.96331, "fair_value_gap": -15.5, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 51.9845, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-1.5% over one week, +6.5% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 63, "badges": [], "opportunities": [], "risks": [], "event_label": "Earnings", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 11}, {"label": "Seeking Alpha", "count": 5}, {"label": "TradingView", "count": 4}, {"label": "GuruFocus", "count": 2}, {"label": "Investor's Business Daily", "count": 2}, {"label": "Simply Wall Street", "count": 2}, {"label": "MarketWatch", "count": 2}, {"label": "Ad Hoc News", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 54}, {"label": "Industry context", "count": 11}, {"label": "Sector context", "count": 1}], "events": [{"label": "Earnings", "count": 34}, {"label": "Market update", "count": 17}, {"label": "Guidance", "count": 4}, {"label": "Analyst action", "count": 3}, {"label": "Regulatory and legal", "count": 2}, {"label": "Macro sensitivity", "count": 2}, {"label": "Capital return", "count": 2}, {"label": "Balance sheet", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Earnings", "tone": "neutral", "text": "77/100 classification confidence."}, {"label": "Company focus", "value": "54", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "12", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-1.5% over one week, +6.5% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Abbott stock powers through 100-DMA, but long-term downtrend still looms (ABT:NYSE)"}], "updated_at": "2026-07-16T17:05:18.278244+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}